The 10-Item Sickle Cell Disease Severity Measure (SCDSM-10): A Novel Measure of Daily SCD Symptom Severity Developed to Assess Benefit of GBT440, an Experimental HbS Polymerization Inhibitor

L Burke; JC Hobart; K Fox; J Lehrer-Graiwer; K Bridges; M Kraus; E Ramos

doi:10.1182/blood.v128.22.4760.4760

The 10-Item Sickle Cell Disease Severity Measure (SCDSM-10): A Novel Measure of Daily SCD Symptom Severity Developed to Assess Benefit of GBT440, an Experimental HbS Polymerization Inhibitor

L Burke
, JC Hobart
, K Fox
, J Lehrer-Graiwer
, K Bridges
, M Kraus
, E Ramos

Peninsula Medical School

Research output: Contribution to conference › Conference paper (not formally published) › peer-review

Original language	English
DOIs	https://doi.org/10.1182/blood.v128.22.4760.4760
Publication status	Published - 2 Dec 2016

Access to Document

10.1182/blood.v128.22.4760.4760

Cite this

@conference{1520bbaf66524bceae45200ba39fd509,

title = "The 10-Item Sickle Cell Disease Severity Measure (SCDSM-10): A Novel Measure of Daily SCD Symptom Severity Developed to Assess Benefit of GBT440, an Experimental HbS Polymerization Inhibitor",

author = "L Burke and JC Hobart and K Fox and J Lehrer-Graiwer and K Bridges and M Kraus and E Ramos",

year = "2016",

month = dec,

day = "2",

doi = "10.1182/blood.v128.22.4760.4760",

language = "English",

}

TY - CONF

T1 - The 10-Item Sickle Cell Disease Severity Measure (SCDSM-10): A Novel Measure of Daily SCD Symptom Severity Developed to Assess Benefit of GBT440, an Experimental HbS Polymerization Inhibitor

AU - Burke, L

AU - Hobart, JC

AU - Fox, K

AU - Lehrer-Graiwer, J

AU - Bridges, K

AU - Kraus, M

AU - Ramos, E

PY - 2016/12/2

Y1 - 2016/12/2

U2 - 10.1182/blood.v128.22.4760.4760

DO - 10.1182/blood.v128.22.4760.4760

M3 - Conference paper (not formally published)

ER -